Additional file 5: Table S6. of Phase 1b/2a study of trastuzumab emtansine (T-DM1), paclitaxel, and pertuzumab in HER2-positive metastatic breast cancer

Summary of ORR by HER2 mRNA expression level as measured by quantitative reverse transcription polymerase chain reaction. (DOC 138 kb)